| Date | Title | Description |
| 16.09.2024 | Autoliv Welcomes Adriana Karaboutis: A New Era in Automotive Safety Leadership | In a strategic move that signals a commitment to innovation and leadership, Autoliv, Inc. has appointed Adriana Karaboutis to its Board of Directors. This decision, effective September 13, 2024, expands the board from eleven to twelve membe... |
| 16.09.2024 | Autoliv Appoints Adriana Karaboutis to its Board of Directors | STOCKHOLM, Sept. 16, 2024 /PRNewswire/ -- Autoliv, Inc. (NYSE: ALV) (SSE: ALIVsdb), the worldwide leader in automotive safety systems, announces that it has added a new independent member to its Board of Directors effective today.
On Septem... |
| 16.09.2024 | Autoliv Appoints Adriana Karaboutis to its Board of Directors | Autoliv Appoints Adriana Karaboutis to its Board of Directors
Mon, Sep 16, 2024 08:00 CET Report this content
(Stockholm, Sweden, September 16, 2024) – Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety sy... |
| 04.08.2024 | Perrigo's Financial Landscape: Navigating Challenges and Opportunities | Perrigo Company plc, a prominent player in the consumer self-care market, recently unveiled its financial results for the second quarter of 2024. The numbers tell a story of resilience amid challenges. With net sales dipping and operational... |
| 02.08.2024 | Perrigo Reports Second Quarter 2024 Financial Results From Continuing Operations | Delivered Adjusted Diluted Earnings Per Share Results as Expected; Reaffirm Fiscal 2024 Adjusted Diluted EPS Outlook
Progressing One Perrigo Blueprint: On Target to Deliver Project Energize Goals; Enhancing Capabilities; Completed Divestmen... |
| 01.08.2024 | Perrigo Announces Quarterly Dividend | DUBLIN, Aug. 1, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.276 per share, payable on Septe... |
| 01.06.2024 | FDA warns against infant formula by Texas firm due to contamination | - |
| 10.05.2024 | Consumers trading down to cheaper goods as inflation persists | figcaption>span]:font-sans">
Call it the big trade down.
Why it matters: Consumers eager to save amid persistently high inflation are increasingly turning to cheaper goods and services.
Between the lines: Low priced items are acc... |
| 07.05.2024 | Perrigo Reports First Quarter 2024 Financial Results From Continuing Operations | Delivered Adjusted Diluted Earnings Per Share Results Above Projection, Due Primarily to Timing of Infant Formula Shipments; Reaffirm 2024 Financial Outlook
Advanced Augmenting and Strengthening of Infant Formula Facilities, Recovery of Man... |
| 19.04.2024 | How will Israel's attack on Iran impact the stock market, crude oil, gold? | - |
| 19.03.2024 | Online sales begin for the first over-the-counter birth control pill in the U.S. | The rollout is underway for the first over-the-counter birth control pill approved in the United States, with online sales kicking off Monday. It will also soon be available in major retailers like CVS and Walgreens.
The pill, known by the ... |
| 08.03.2024 | Global Nicotine Gum Market by Dosage & Distribution - Forecast 2024-2030 | - |
| 11.09.2022 | Perrigo unveils $170 million investment plan | DUBLIN — Private label manufacturer Perrigo Company PLC is investing a total of $170 million into expanding its US infant formula production capacity.
As part of its new strategic investment plan, Perrigo purchased Nestle SA’s Gateway formu... |
| 10.11.2021 | Perrigo Reports Third Quarter 2021 Financial Results From Continuing Operations | DUBLIN, Nov. 10, 2021 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced financial results for the third quarter of fis... |
| 02.11.2021 | Perrigo Announces Quarterly Dividend | DUBLIN, Nov. 2, 2021 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.24 per share, ... |
| 03.08.2021 | Perrigo Announces Quarterly Dividend | |
| 07.07.2021 | The weirdly sensical business of weather TV | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Paid Content Why the Electricity 4.0 moment is here From Schneider Electric
On most mornings, I w... |
| 07.07.2021 | The weirdly sensical business of weather TV | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Paid Content Does your company need a Chief A.I. Ethics Officer, an A.I. Ethicist, an A.I. Ethics... |
| 11.05.2021 | Perrigo Reports First Quarter 2021 Financial Results From Continuing Operations | |
| 19.04.2021 | Infogix Experts to Address Data Governance Best Practices in Two Sessions During Enterprise Data World 2021 | "Data governance requires organizational alignment, clear objectives, detailed business rules and an enterprise-wide framework to establish data understanding and trust."
NAPERVILLE, Ill. (PRWEB) April 19, 2021
Infogix, a leading ... |
| 19.04.2021 | Perrigo Announces Quarterly Dividend | |
| 01.03.2021 | Perrigo Reports Fourth Quarter & Fiscal Year 2020 Financial Results | |
| 04.11.2020 | Perrigo Reports Third Quarter 2020 Financial Results | |
| 21.11.2017 | Term Sheet — Tuesday, November 21 | WOMEN ONLY
Good morning, Term Sheet readers.
Paid Content What you need to know about growing cyberattacks From ExtraHop
The Wing, a women-only club and co-working space, launched its first location a year ago in the Flatiron District of Ne... |
| 11.08.2017 | Term Sheet — Friday, Aug. 11 | BLIND EYE TO SIDE EYE
Hello. How about that slow news day yesterday?
Paid Content How to secure an enterprise without boundaries From ExtraHop
The lawsuit argues that if Benchmark had known about Kalanick’s “gross mismanagement and other mi... |
| 02.12.2015 | Belgian billionaire Marc Couke invests in Sophia Genetics | |
| 07.11.2013 | Arizona healthcare startup raises $50K for its wet AMD treatment | “Brachytherapy for wet AMD has the potential, as a one time treatment, to drive efficacious outcomes as well as reduce the need for anti-VEGF injections.”
This, he said, could take the cost out of care as the anti-VEGF injections, the bi-mo... |
| 19.05.2011 | Generic of UCB allergy med Xyzal gets preliminary FDA approval for Synthon | Synthon said it believes it is the first to file an application with the FDA for a Xyzal generic. Being first to file gives Synthon the advantage of 180 days of marketing exclusivity over other Xyzal generics.
The FDA approved Belgium-based... |
| 20.01.2011 | Generic drug acquisition: Perrigo buys Minnesota’s Paddock Labs | Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth ... |
| 01.03.2010 | Perrigo to buy Australian over-the-counter drugmaker for $48M | Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth ... |
| - | Arizona healthcare startup raises $50K for its wet AMD treatment | Tucson, Ariz.-based healthcare startup Salutaris Medical Devices has raised $50,000 in debt financing so far in its quest to reach $1 million, according to a regulatory filing made with the SEC. The funding will support the 5-year-old compa... |
| - | Generic drug acquisition: Perrigo buys Minnesota’s Paddock Labs | Over-the-counter drugmaker Perrigo has acquired Minneapolis-based Paddock Labs for $540 million, adding $200 million per year in revenue to the bottom line of the world’s largest drug company.
The purchase expands Perrigo’s presence in the ... |
| - | Generic of UCB allergy med Xyzal gets preliminary FDA approval for Synthon | Generic drug company Synthon Pharmaceuticals has received tentative U.S. Food and Drug Administration approval on its application to make a version of UCB‘s (EBR:UCB) allergy medicine Xyzal.
Netherlands-based Synthon, which has its U.S. hea... |
| - | Camden Portfolio Company Ranir Acquired by Leading Global Self-Care Company Perrigo | BALTIMORE, MARYLAND — July 1, 2019 — Camden Partners is pleased to announce Ranir, LLC, a Camden Partners portfolio company, has been acquired by Perrigo Company plc (NYSE: PRGO), a leading global provider of Quality, Affordable Self-Care P... |
| - | Perrigo to buy Australian over-the-counter drugmaker for $48M | Perrigo Co. has reached a $48 million agreement to acquire an Australian over-the-counter, store-brand pharmaceuticals supplier.
Perrigo, which bills itself as the world’s largest manufacturer of over-the-counter drugs for the store-brand m... |
